Global Scientific Affairs Director, COVID-19 and Flu
Johns Hopkins Bloomberg School of Public Health
Kayte Andersen is the Global Scientific Affairs Director, COVID-19 and Flu Pfizer's Vaccines and Antivirals group, where she implements causal inference and machine learning techniques to answer population-level questions related to COVID-19. She holds a BSc in Pharmacology & Therapeutics from McGill University, an MSc focused on pharmacoepidemiology from McGill University, and a PhD in Epidemiology with a graduate certificate in pharmacoepidemiology and drug safety from the Johns Hopkins Bloomberg School of Public Health.